In VitroRelease Kinetics of Antituberculosis Drugs from Nanoparticles Assessed Using a Modified Dissolution Apparatus

A two-stage reverse dialysis in vitro dissolution testing method for passive targeted liposomes

(2012) Xiaoming Xu et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Supramolecular assemblies of rifampicin and cationic bilayers: preparation, characterization and micobactericidal activity

(2011) Lilian Barbassa et al.   BMC BIOTECHNOLOGY

DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles

(2010) Yong Zhang et al.   AAPS Journal

Biomarker-Assisted Dose Selection for Safety and Efficacy in Early Development of PNU-100480 for Tuberculosis

(2010) Robert S. Wallis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus I

(2010) Mona M.A. Abdel-Mottaleb et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Secondary cytotoxicity mediated by alveolar macrophages: A contribution to the total efficacy of nanoparticles in lung cancer therapy?

(2010) Kamal M.H.D Al-Hallak et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

A novel USP apparatus 4 based release testing method for dispersed systems

(2010) Upkar Bhardwaj et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Effects of technical parameters on the physicochemical properties of rifampicin-containing polylactide nanoparticles

(2010) O. O. Maksimenko et al.   PHARMACEUTICAL CHEMISTRY JOURNAL

Biowaiver monographs for immediate release solid oral dosage forms: Rifampicin

(2009) C. Becker et al.   JOURNAL OF PHARMACEUTICAL SCIENCES